Morgan Stanley 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 4:55 pm Sale |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
MORGAN STANLEY MS |
1,319,809 1.700% |
-2,832,637 (-68.22%) |
Filing |
| 2024-02-09 10:33 am Purchase |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
MORGAN STANLEY MS |
4,152,446 5.500% |
4,152,446 (New Position) |
Filing |